{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:36:05Z","timestamp":1789425365766,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jaci.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T22:08:29Z","timestamp":1611266909000},"page":"262-265.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analyses"],"prefix":"10.1016","volume":"148","author":[{"given":"Alberto","family":"Papi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann Christian","family":"Virchow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Kots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Walter","family":"Canonica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.01.007_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/thx.2005.045161","article-title":"Asthma exacerbations, 1: epidemiology","volume":"61","author":"Johnston","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.jaci.2021.01.007_bib2","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jaci.2008.08.003","article-title":"Epidemiology of asthma exacerbations","volume":"122","author":"Sears","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.007_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/02770903.2018.1514627","article-title":"The association of environmental, meteorological, and pollen count variables with asthma-related emergency department visits and hospitalizations in the Bronx","volume":"56","author":"Witonsky","year":"2019","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2021.01.007_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/cea.12419","article-title":"Epidemiology of asthma exacerbations and their relation with environmental factors in the Basque Country","volume":"45","author":"Altzibar","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.01.007_bib5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1164\/ajrccm.154.3.8810601","article-title":"The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis","volume":"154","author":"Johnston","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2021.01.007_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2500\/aap.2018.39.4162","article-title":"Seasonal variability of exacerbations of severe, uncontrolled eosinophilic asthma and clinical benefits of benralizumab","volume":"39","author":"DuBuske","year":"2018","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaci.2021.01.007_bib7","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jaci.2017.01.028","article-title":"Seasonal variability of severe asthma exacerbations and clinical benefit from lebrikizumab","volume":"139","author":"Staton","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.007_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00964-2019","article-title":"Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma","volume":"55","author":"FitzGerald","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.01.007_bib9","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.01.007_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2021.01.007_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.rmed.2015.01.012","article-title":"Defining moderate asthma exacerbations in clinical trials based on ATS\/ERS joint statement","volume":"109","author":"Virchow","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2021.01.007_bib12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.01.007_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1398-9995.2007.01393.x","article-title":"Allergenic pollen and pollen allergy in Europe","volume":"62","author":"D\u2019Amato","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.01.007_bib14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.05.028","article-title":"Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor \u03bab and c-Jun N-terminal kinase activation","volume":"132","author":"Papi","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.01.007_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fcimb.2020.00278","article-title":"Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells","volume":"10","author":"Wang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jaci.2021.01.007_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1183\/09031936.00065111","article-title":"Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells","volume":"40","author":"Yamaya","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.01.007_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000151729","article-title":"Tiotropium bromide attenuates respiratory syncytial virus replication in epithelial cells","volume":"76","author":"Iesato","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.jaci.2021.01.007_bib18","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","article-title":"Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials","volume":"394","author":"Virchow","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.01.007_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.rmed.2015.01.012","article-title":"Defining moderate asthma exacerbations in clinical trials based on ATS\/ERS joint statement","volume":"109","author":"Virchow","year":"2015","journal-title":"Respir Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:33:04Z","timestamp":1758792784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0091674921000865"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.01.007","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrafine triple therapy and asthma exacerbation seasonality: TRIMARAN and TRIGGER post hoc analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}